Moirai Biodesign’s General Shareholders Ordinary Meeting will be held on July, 18th, at 10:00h. Please find the agenda here. Please find the proxy here (english / spanish)
MoreFounded on the combination of cutting-edge synthetic biology and computational biology, Moirai Biodesign is putting RNA design at the service of biomedicine.
We envision our technologies and expertise as the catalysts of a healthcare ecosystem where rapid and affordable diagnostic methods are an option for all patients worldwide.
Amadís Pagès
Co-Founder and CEO
Ivan Dotu
Co-founder and CTO
Daniel Poglayen
Co-founder and CPDO
Cristina Alsina
Research Scientist
Judit Domingo
Product Developer
Gerard Minuesa
Research Scientist
Moirai Biodesign’s General Shareholders Ordinary Meeting will be held on June, 29th, at 10:00h. Please find the agenda here. Please find the proxy here (english / spanish)
More
Moirai Biodesign’s General Shareholders Extraordinary Meeting will be held on January, 31st, at 11:00h. Please find the agenda here. Please find the proxy here (english / spanish)
More
Moirai Biodesign’s General Shareholders Extraordinary Meeting will be held on December, 23rd, at 10:00h. Please find the agenda here. Please find the proxy here (english / spanish)
More
Moirai Biodesign’s General Shareholders Meeting will be held on July, 22nd, at 10:00h. Please find the agenda here.
More
Moirai Biodesign’s General Shareholders Meeting is suspended due to agenda issues. Please find the official communication here.
More